Rayonier (RYAM) Q2 2026 Earnings Call Transcript

Rayonier Advanced Materials (RYAM) reported Q2 net sales of $376M, up 18% sequentially and 11% year-over-year, while adjusted EBITDA rose to $40M from $8M in Q1 and improved the loss from continuing operations to $33M (vs. $81M in Q1). High Purity Cellulose drove the outperformance, with pricing up 21% y/y and adjusted EBITDA increasing to $57M (19% margins vs. 9% in Q1), partially offset by paperboard & high-yield pulp EBITDA of -$10M. Liquidity ended at $145M and net secured leverage was 4.2x covenant EBITDA (below the 4.75x limit); management reiterated guidance for positive 2026 free cash flow and expects HPC back-half volume growth of 10%–15%. However, the company flagged tariff risk from U.S. Section 301 actions—37.5% on Brazilian dissolving wood pulp and 12.5% on Norwegian imports—and said these could materially impact paperboard/high-yield pulp economics.

Analysis

RYAM is less a clean operating recovery story than a three-layer option: near-term tariff-driven pricing power in specialty cellulose, medium-term covenant/refi relief if EBITDA holds, and a binary strategic-review outcome in Q4. The market should treat the current inflection as more durable in HPC than in paperboard; specialty margins can re-rate quickly because customers care about continuity and qualification, while paperboard economics remain hostage to freight, maintenance, and policy drift. The key second-order effect is that import restrictions may not just lift RYAM pricing — they can force competitors to re-route volumes into non-U.S. markets, depressing global dissolving pulp spreads and limiting the duration of the uplift.

The balance-sheet path matters more than the headline beat. At this leverage level, the equity trades like a credit call option: if back-half CS volumes miss or new-product qualification slips, the 2027 refinance story weakens and equity multiple compression can overwhelm any tariff benefit. Conversely, if management converts pricing into sustained free cash flow, the stock could gap on the perception of a lower default probability well before absolute earnings improve. The most important falsifier is not one quarter of EBITDA; it is whether year-end liquidity and covenant headroom trend toward a credible refinancing window.

Contrarian take: the consensus is likely overstating tariff benefits and understating strategic value. Tariffs can be partially offset by downstream exemptions, customer repricing, or inventory timing, but the sole-U.S.-supplier defense angle and differentiated HPC asset base may be worth more in a sale process than in stand-alone economics. That argues for upside skew into Q4, but only if the review produces a concrete path rather than another process update.

Key Decisions for Investors

• Tactically long RYAM into pullbacks over the next 4-8 weeks; treat it as an event-driven situation with Q4 strategic-review upside and tariff optionality, but size modestly because leverage makes this a credit-sensitive equity.
• If holding RYAM already, reduce into any sharp rally ahead of the Q4 review deadline unless there is evidence of sustained HPC volume growth and positive free cash flow conversion; the main falsifier is a slip back in EBITDA or liquidity metrics.
• Watch for a pair trade opportunity: long RYAM vs short a basket of import-exposed specialty pulp producers or downstream customers that lack pricing power if Section 301 duties stick; the relative winner should be the qualified U.S. supplier with the tightest customer spec-in.
• For higher-conviction upside, prefer call-spread exposure rather than outright common if liquidity allows; the thesis is binary around strategic-review outcome and refinancing optics, so defined-risk convexity is preferable to taking full balance-sheet risk.